🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 1-year, open-label, long-term safety extension for patients who h...
Status
Completed
Location
Kyowa Pharmaceutical Inc.
Start Date
2004-10
Trial ID
NCT00199368
Treatments Being Tested
The purpose of this study is to confirm the long term tolerability and safe...
Status
Completed
Location
The University of Chicago
Start Date
2005-03
Trial ID
NCT00203957
Treatments Being Tested
Patients with Parkinson's disease who completed the prior double-blind stud...
Status
Completed
Location
Multiple Locations
Start Date
2009-10
Trial ID
NCT00957203
Treatments Being Tested
This is a Phase 3, 52-week, open-label, flexible-dose, multinational, multi...
Status
Completed
Location
Kyowa PD Site
Start Date
2015-12
Trial ID
NCT02610231
Treatments Being Tested
This is an, open-label, long-term safety extension for patients in North Am...
Status
Terminated
Location
Kyowa Pharmaceutical Inc.
Start Date
2005-10
Trial ID
NCT00199381
Treatments Being Tested
The purpose of this study is to test whether Rifampin affects blood levels ...
Status
Completed
Location
Celerion, Inc.
Start Date
2014-06
Trial ID
NCT02174250
Treatments Being Tested